Expanding interests into metabolic disorders have led to the proposal of how metabolic disorders and Alzheimer’s disease have overlapping risk factors, which generated interests of PPAR in Alzheimer’s disease. This evidence concerns the gene PPARA and early-onset autosomal dominant Alzheimer disease.